GeneDx Holdings Corp. (WGS) Misses Q2 EPS by 174c

GeneDx Holdings Corp. (NASDAQ: WGS) reported Q2 EPS of ($1.84), $1.74 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $48.71 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Wall Street scrambles to lift Micron price targets ahead of earnings